MedPath
FDA Approval

Phenytoin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
October 31, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Phenytoin(125 mg in 5 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

American Health Packaging

American Health Packaging

929561009

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Phenytoin

Product Details

NDC Product Code
60687-275
Application Number
ANDA040521
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 31, 2022
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8Class: IACT
MAGNESIUM ALUMINUM SILICATEInactive
Code: 6M3P64V0NCClass: IACT
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORMInactive
Code: K679OBS311Class: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
POLYSORBATE 60Inactive
Code: CAL22UVI4MClass: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT
PhenytoinActive
Code: 6158TKW0C5Class: ACTIBQuantity: 125 mg in 5 mL
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
© Copyright 2025. All Rights Reserved by MedPath